Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid serves as a key drug intermediate in the synthesis of a variety of active pharmaceutical compounds. Its unique chemical structure allows for versatile applications in medicinal chemistry, facilitating the development of novel therapeutic agents. This compound is essential for researchers involved in drug design and synthesis. -
Drug Impurity
Ethinylestradiol impurity 3 is a known impurity associated with the synthesis of Ethinylestradiol, a synthetic estrogen used in various hormonal therapies. This compound can be utilized in quality control and analytical studies to evaluate the purity of Ethinylestradiol formulations. Its presence in pharmaceutical preparations can affect the efficacy and safety profiles of estrogenic treatments, making it relevant in drug development and regulatory assessments. -
Drug Impurity
Apixaban impurity 46 is a characterized impurity associated with the anticoagulant Apixaban. This compound is crucial for the quality control and validation processes in pharmaceutical research, aiding in the assessment of drug purity and stability. Its analysis is essential for ensuring compliance with regulatory standards in drug development and manufacturing, ultimately contributing to safer therapeutic applications. -
Drug Intermediate
3-(3,5-Dichlorophenyl)-1-methylhydantoin is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound serves as a building block in pharmaceutical research, facilitating the development of novel therapeutics. Its unique chemical structure aids in the exploration of diverse medicinal applications, making it an essential reagent for researchers in drug discovery and development. -
Drug Impurity
Ondansetron impurity 6 is a known impurity associated with the antinausea medication Ondansetron. This compound is essential for assessing the purity and quality of pharmaceutical formulations containing Ondansetron. It serves a critical role in research focused on drug development, formulation stability, and regulatory compliance by providing insights into the compound's synthesis and degradation pathways. -
Drug Intermediate
2-Methyl-2-propanyl(1S,8R)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate serves as a key drug intermediate in the synthesis of diverse biologically active compounds. This compound is important for creating novel agents with potential therapeutic applications, facilitating research in medicinal chemistry and pharmacology. Its structural attributes enable the development of derivatives that can target various biological pathways. -
Drug Impurity
Methyl 2-formyl-5-methoxybenzoate is identified as a drug impurity. This compound may participate in various analytical studies aimed at assessing the purity of pharmaceutical formulations. It is useful for researchers investigating the stability and degradation pathways of benzoate derivatives within the context of drug development. -
Drug Impurity
Methyl 5-formylsalicylate is a recognized drug impurity associated with various pharmaceutical compounds. This compound can serve as an important analytical marker for quality control and stability testing throughout drug development processes. Its examination can provide insights into the metabolic pathways and degradation products of certain drug formulations, aiding in the evaluation of safety and efficacy. -
Drug Impurity
Nintedanib impurity 9 is a specific impurity associated with the drug Nintedanib, which serves as a multiple receptor kinase inhibitor targeting VEGFR, PDGFR, and FGFR. This compound is utilized in research to assess the purity and quality of Nintedanib formulations. Its identification is crucial for compliance with regulatory standards in drug development and quality control processes. -
Drug Intermediate
5,6,7,8-Tetrahydro-2-naphthoic acid is a synthetic intermediate utilized in pharmaceutical synthesis. It serves as a key building block in the development of various therapeutic compounds, facilitating the design of biologically active molecules. This compound is particularly valuable in drug discovery and medicinal chemistry applications. -
Drug Impurity
Glycopyrronium impurity 4 is a chemical impurity associated with the synthesis of Glycopyrronium, a muscarinic receptor antagonist. This impurity is relevant for quality control and regulatory compliance during the development and manufacture of pharmaceutical formulations. It can be utilized in analytical studies to assess the purity and stability of Glycopyrronium formulations. -
Drug Intermediate
Bis(acetoxymethyl) 2,2'-((tert-butoxycarbonyl)azanediyl)diacetate serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the incorporation of functional groups in medicinal chemistry applications, aiding in the development of novel therapeutic agents. Its versatility in synthetic pathways contributes significantly to pharmaceutical research and development initiatives. -
Drug Intermediate
rel-Ethyl (2R,3S)-2,3-dimethylcyclopropanecarboxylate serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This compound is utilized in medicinal chemistry for the preparation of pharmaceuticals, allowing for the development of new therapeutic agents. Its structural characteristics facilitate various chemical reactions, making it an essential reagent in organic synthesis. -
Drug Impurity
Cinakase impurity 11 is a byproduct associated with the synthesis of Cinakase, a medication used for the treatment of certain hematological malignancies. This impurity is essential for analytical validation and quality control in pharmaceutical research. Its characterization aids in ensuring the safety and efficacy of the final therapeutic product, facilitating compliance with regulatory standards in drug development. -
Drug Impurity
Sitagliptin impurity 5 is a structural variant of Sitagliptin, primarily characterized as a drug impurity. It is utilized in pharmaceutical research and development to understand the profiles and effects of Sitagliptin formulations. This impurity plays a crucial role in chromatographic analysis and quality control assessments of Sitagliptin products, ensuring the integrity and safety of therapeutic compounds. -
Drug Impurity
Prednisolone Impurity 9 is a chemical impurity associated with the corticosteroid prednisolone. Characterizing this impurity is essential for ensuring the quality and safety of pharmaceutical formulations. This reagent is utilized in analytical and quality control studies to identify and quantify impurities, contributing to the overall understanding of drug stability and efficacy. -
Drug Impurity
Furosemide Impurity 7 is a chemical impurity associated with the pharmaceutical compound Furosemide. As a drug impurity, it is relevant for studies focusing on pharmaceutical quality control and toxicological assessments. Research applications include the evaluation of drug purity and stability, as well as understanding the implications of impurities in drug formulations. -
Drug Impurity
Ticagrelor impurity 20 is a chemical impurity associated with the antiplatelet agent Ticagrelor. This compound serves as an important reference standard in the evaluation of Ticagrelor quality and purity. It is utilized in pharmaceutical research and development to ensure the integrity of formulations containing Ticagrelor and to study the effects of impurities on drug efficacy and safety. -
Drug Intermediate
1,7-Diazaspiro[4.5]decan-6-one hydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique spirocyclic structure facilitates the development of pharmacologically relevant molecules, enhancing research in medicinal chemistry and drug discovery. This compound is utilized in the production of a variety of therapeutic agents, contributing to advancements in pharmaceutical applications. -
Drug Impurity
Peracetyl Empagliflozin is a known drug impurity related to the SGLT2 inhibitor Empagliflozin. This compound may be utilized in the study of pharmaceutical formulations and stability testing, helping to assess the quality and safety of drug products. Its characterization can provide valuable insights into synthesis pathways and potential degradation mechanisms, supporting research in drug development and regulatory compliance. -
Drug Impurity
Avibactam impurity 1 is a chemical impurity associated with Avibactam, a β-lactamase inhibitor. This compound is critical for quality control and characterization in pharmaceutical research and development. Its analysis is essential for ensuring the purity of Avibactam in clinical formulations and contributes to investigations on drug stability and efficacy. -
Drug Impurity
Dapagliflozin impurity 57 is a chemical impurity associated with Dapagliflozin, an SGLT2 inhibitor used in the treatment of type 2 diabetes. This compound serves as a key reference standard for analytical characterization and quality control in pharmaceutical research. Its presence is crucial for ensuring the purity and safety of therapeutic formulations containing Dapagliflozin, making it essential for regulatory compliance and stability testing. -
Drug Impurity
Ropivacaine impurity 1 hydrochloride is a known impurity related to the local anesthetic Ropivacaine. This compound serves as an important reference standard for the assessment of drug quality and purity in pharmaceutical research and development. Its characterization is crucial for regulatory compliance and ensuring the safety and efficacy of Ropivacaine formulations. -
Drug Impurity
Methotrexate impurity 6 is a known impurity associated with the chemotherapeutic agent Methotrexate. This compound is primarily used for analytical purposes in pharmacokinetic studies and quality control processes. It serves as a reference standard for identifying and quantifying impurities in pharmaceutical formulations containing Methotrexate. -
Drug Intermediate
2-Amino-5-bromobenzophenone is a key intermediate in pharmaceutical synthesis, primarily targeting drug development. This compound features a bromine substitution on the benzophenone structure, facilitating its use in the production of various biologically active compounds. It is utilized in the exploration of new therapeutic agents and in research related to medicinal chemistry. -
Drug Impurity
Ticagrelor impurity 25 is a synthetic impurity associated with the antiplatelet agent Ticagrelor, acting primarily on the P2Y12 receptor to inhibit platelet aggregation. This compound serves as a crucial reference material in the analysis and quality control of Ticagrelor formulations, ensuring the purity and efficacy of the drug. Its characterization is essential for pharmacokinetic studies and the development of regulatory guidelines in pharmaceutical research. -
Drug Impurity
Trimetazidine impurity 10 is a chemical impurity associated with the cardioprotective agent Trimetazidine. As a research reagent, it can be utilized in the analysis of Trimetazidine's purity and stability, helping to ensure compliance with pharmacological standards. This impurity is significant for studies involving drug formulation and quality control in pharmaceutical research. -
Drug Intermediate
3-Formyl-1-(phenylsulphonyl)-1H-indole serves as a versatile drug intermediate in the synthesis of various biologically active compounds. Its structure facilitates the formulation of indole derivatives, which are significant in medicinal chemistry. This compound is particularly useful in research applications focused on the development of pharmaceuticals with targeted therapeutic effects. -
Drug Impurity
Sorafenib impurity 6 is a known impurity of the multikinase inhibitor Sorafenib, targeting various receptor tyrosine kinases involved in tumor angiogenesis and cell proliferation. This compound serves as a useful reference standard in analytical chemistry and pharmacokinetic studies to assess the purity of Sorafenib formulations. Its characterization aids in ensuring the quality and efficacy of pharmaceutical products containing Sorafenib. -
Drug Intermediate
N-(5-Chloropyridin-2-yl)-2-(4-cyanobenzamido)-5-methoxybenzamide serves as a versatile drug intermediate utilized in the synthesis of active pharmaceutical compounds. Its unique chemical structure enables the production of various biologically active molecules, making it valuable in medicinal chemistry research. This compound is essential for developing new therapeutic agents aimed at a range of diseases. -
Drug Impurity
Afatinib impurity 3 is a quantified impurity of Afatinib, a selective irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. This compound is primarily utilized in the evaluation of drug purity and quality control in pharmaceutical research and development. Its characterization is essential for compliance with regulatory standards and for ensuring the safety and efficacy of Afatinib-based therapies. -
Drug Impurity
Apixaban impurity 11 is a known impurity associated with the anticoagulant Apixaban. This compound is essential for the characterization of Apixaban in pharmaceutical formulations and stability studies. Its presence and quantification are important in ensuring the quality and efficacy of the drug during development and production processes. -
Drug Impurity
Ropinirole impurity 12 is a chemical impurity associated with the analgesic and anti-Parkinson agent, Ropinirole. This compound plays a critical role in the assessment of drug purity and stability, as it can potentially affect the pharmacological profile of the parent compound. Additionally, Ropinirole impurity 12 is useful in research focused on formulation development, quality control, and compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Indobufen Impurity 6 is a structural impurity associated with Indobufen. It serves as a valuable reference standard for analytical and quality control applications in pharmaceutical research. The characterization of this impurity can aid in assessing the purity and stability of Indobufen formulations, contributing to the understanding of its pharmacological properties. -
Drug Intermediate
Tofacitinib Impurity T is a synthetic intermediate primarily used in the production of bioactive compounds. This compound consists of a propanamide moiety linked to a piperidinyl group and is relevant for research focused on the synthesis of therapeutic agents. Its role as a building block in organic chemistry facilitates the development of novel pharmaceuticals targeting various diseases. -
Drug Impurity
Terbinafine impurity 1 hydrochloride is a known impurity of the antifungal agent terbinafine hydrochloride. This compound is important for analytical studies focused on drug purity, stability, and formulation development. Researchers can use it to validate analytical methods and ensure compliance with regulatory standards in pharmaceutical testing. -
Drug Impurity
Metoprolol impurity 10 is a characterized impurity of the beta-blocker Metoprolol, primarily affecting the drug's purity assessment and quality control. Its analysis is essential in pharmaceutical research to ensure compliance with regulatory standards. This compound serves as a reference for detecting and quantifying impurities in formulation studies and stability assessments of Metoprolol. -
Drug Impurity
Dronedarone impurity 25 hydrochloride is a designated impurity associated with the antiarrhythmic drug Dronedarone. It serves as a crucial reference standard in the analysis and quality control of Dronedarone, facilitating the evaluation of drug purity and stability. This compound is significant for researchers and pharmaceutical developers engaged in the synthesis, development, and regulatory assessment of cardiovascular therapeutics. -
Drug Intermediate
Benzeneethanamine, 2-bromo-α,α-dimethyl serves as a crucial drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound exhibits significant potential in medicinal chemistry, particularly in the development of novel therapeutic agents. Its unique structural properties make it a valuable building block in pharmaceutical research and development. -
Drug Impurity
Sitagliptin impurity 29 is a known impurity of the DPP-4 inhibitor Sitagliptin. Its identification and characterization are crucial for assessing the purity of Sitagliptin during drug development and quality control processes. This compound is important for researchers investigating the safety, efficacy, and regulatory compliance of Sitagliptin formulations. -
Drug Intermediate
1,2,3-Trimethoxybenzene serves as a drug intermediate, particularly in the synthesis of 2,6-dimethoxy-1,4-benzoquinone. As a derivative of lignin, it is of interest in studies involving natural compounds and serves as a potential biomarker for certain dietary sources, notably in tea. Its chemical properties and biological relevance make it valuable for research applications in pharmacology and food sciences. -
Drug Impurity
Posaconazole impurity 4 is a characterized impurity of the antifungal agent Posaconazole. It serves as a reference standard for analytical studies and quality control processes in pharmaceutical research. The identification and quantification of this impurity are essential for ensuring the purity and efficacy of Posaconazole formulations in clinical settings. -
Drug Impurity
Sofosbuvir impurity 3 is a characterized impurity of the antiviral agent Sofosbuvir, primarily targeting hepatitis C virus replication. This compound serves as a vital reference standard in the analytical evaluation of Sofosbuvir formulations, ensuring the quality and safety of therapeutic applications. Its assessment is crucial for researchers conducting studies on drug metabolism, stability, and impurity profiling in pharmaceutical development. -
Drug Intermediate
5,6,7,8-Tetrahydro-2-quinolone is a synthetic intermediate utilized in pharmaceutical synthesis. This compound serves as a critical building block in the development of various therapeutic agents. Its chemical structure facilitates the formation of biologically active derivatives, making it a valuable reagent for drug discovery and development. -
Drug Intermediate
2-Nitrobenzamide is a versatile drug intermediate known for its role in the synthesis of various active pharmaceutical compounds. It serves as a key building block in organic synthesis, facilitating the development of biologically active substances. This compound is particularly valuable in medicinal chemistry and pharmaceutical research, supporting the exploration of novel therapeutics. -
Drug Impurity
Brimonidine impurity 7, also known as 6-Quinoxalinamine, is a chemical impurity associated with the synthesis of Brimonidine. This compound serves as an important reference standard in analytical chemistry for the detection and quantification of impurities in pharmaceutical formulations. Its characterization can aid in understanding the stability and quality of Brimonidine-related products. -
Drug Impurity
Sacubitrilat impurity 34 is a known impurity associated with Sacubitrilat, a vasodilator that inhibits neprilysin, thereby increasing levels of natriuretic peptides. This compound is primarily utilized in drug development and quality control assessments to ensure the purity of Sacubitrilat formulations. Its presence in analytical studies aids in understanding the metabolism and safety profiles of the parent drug. -
Drug Impurity
Dapagliflozin impurity 111 is an impurity associated with the antidiabetic agent Dapagliflozin, which targets sodium-glucose cotransporter 2 (SGLT2). This compound serves as a critical analytical reference for the assessment of drug purity and quality control in pharmaceutical formulations. The study of this impurity is important for understanding the stability and safety profiles of SGLT2 inhibitors in drug development. -
Drug Impurity
Vitamin Impurity 3 is a recognized impurity associated with Vitamin compounds. It may arise during synthesis or degradation processes and is primarily investigated for its potential effects on the stability and efficacy of vitamin formulations. This reagent is essential for quality control and regulatory compliance in pharmaceutical research, allowing scientists to assess the purity of vitamin products and their implications for safety and effectiveness. -
Drug Intermediate
5-(M-Tolyl)tetrazole serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This tetrazole derivative is employed in medicinal chemistry for the development of pharmaceuticals, offering a versatile building block for various therapeutic agents. Its unique structure allows for the potential modification and enhancement of biological activity in target compounds, making it an essential reagent for chemical research and drug development.
